These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Mesenchymal Stem Cell Therapy for the Treatment of Heart Failure Caused by Ischemic or Non-ischemic Cardiomyopathy: Immunosuppression and Its Implications. Lipinski MJ; Luger D; Epstein SE Handb Exp Pharmacol; 2017; 243():329-353. PubMed ID: 28382469 [TBL] [Abstract][Full Text] [Related]
23. Autologous and allogeneic cardiac stem cell therapy for cardiovascular diseases. Sanz-Ruiz R; Fernández-Avilés F Pharmacol Res; 2018 Jan; 127():92-100. PubMed ID: 28554583 [TBL] [Abstract][Full Text] [Related]
26. Stem cells for clinical use in cardiovascular medicine: current limitations and future perspectives. Menasché P Thromb Haemost; 2005 Oct; 94(4):697-701. PubMed ID: 16270619 [TBL] [Abstract][Full Text] [Related]
28. [Perspectives in cardiac cell therapy]. Menasché P Presse Med; 2007 Mar; 36 Spec No 1():1S55-8. PubMed ID: 17546769 [TBL] [Abstract][Full Text] [Related]
29. Cell therapy for heart failure--muscle, bone marrow, blood, and cardiac-derived stem cells. Ott HC; Davis BH; Taylor DA Semin Thorac Cardiovasc Surg; 2005; 17(4):348-60. PubMed ID: 16428043 [TBL] [Abstract][Full Text] [Related]
30. [Chinese expert consensus on autologous stem cell transplantation for the treatment of heart failure (2022)]. Heart Regeneration Group, Tissue Repair and Regeneration Branch of the Chinese Medical Association Zhonghua Yi Xue Za Zhi; 2023 May; 103(18):1376-1385. PubMed ID: 37150690 [TBL] [Abstract][Full Text] [Related]
31. Allogenic benefit in stem cell therapy: cardiac repair and regeneration. Al-Daccak R; Charron D Tissue Antigens; 2015 Sep; 86(3):155-62. PubMed ID: 26206374 [TBL] [Abstract][Full Text] [Related]
34. Stem cells for the treatment of heart failure. Kearns-Jonker M; Dai W; Kloner RA Curr Opin Mol Ther; 2010 Aug; 12(4):432-41. PubMed ID: 20677094 [TBL] [Abstract][Full Text] [Related]
35. Skeletal myoblasts as a therapeutic agent. Menasché P Prog Cardiovasc Dis; 2007; 50(1):7-17. PubMed ID: 17631434 [TBL] [Abstract][Full Text] [Related]
38. Intracoronary artery transplantation of cardiomyoblast-like cells from human adipose tissue-derived multi-lineage progenitor cells improve left ventricular dysfunction and survival in a swine model of chronic myocardial infarction. Okura H; Saga A; Soeda M; Miyagawa S; Sawa Y; Daimon T; Ichinose A; Matsuyama A Biochem Biophys Res Commun; 2012 Sep; 425(4):859-65. PubMed ID: 22898045 [TBL] [Abstract][Full Text] [Related]
39. Stem cells in the management of advanced heart failure. Menasché P Curr Opin Cardiol; 2015 Mar; 30(2):179-185. PubMed ID: 25500893 [TBL] [Abstract][Full Text] [Related]
40. Cell transplantation: a novel perspective in the treatment of heart failure. Chierchia S; Deferrari L Ital Heart J; 2004 Jun; 5 Suppl 6():108S-115S. PubMed ID: 15185923 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]